Considering that, as mentioned above [323], serum SelP levels are also elevated in people with type-2 diabetes compared with normal subjects, the study suggests that the secretory protein SelP could represent a target to develop new therapeutic strategies for the treatment of insulin resistance-associated diseases. Here, SELP is linked to Insulin resistance.